Finance

Beta
Lists
4594:TYO
BrightPath Biotherapeutics Co Ltd
Â¥53.00
-1.85%
(-1.00) 1D
Jun 2, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4594...
Open
Â¥53
High
Â¥54
Low
Â¥51
Mkt. cap
7.36B
Avg. vol.
2.17M
Volume
2.38M
52-wk high
Â¥114
52-wk low
Â¥39
EPS
-Â¥12
Shares outstanding
41.98M
No. of employees
24
Open
Â¥53
High
Â¥54
Low
Â¥51
Mkt. cap
7.36B
Avg. vol.
2.17M
Volume
2.38M
52-wk high
Â¥114
52-wk low
Â¥39
EPS
-Â¥12
Shares outstanding
41.98M
No. of employees
24
News stories
From sources across the web
About BrightPath Biotherapeutics Co Ltd
CEO-
Employees24
FoundedMay 8, 2003
Headquarters-
SectorBiotechnology
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Dec 2024
Jun 2025
Sep 2025
Dec 2025
Revenue
33.00K
16.50K
16.50K
-
Cost of goods sold
8.00K
4.00K
4.00K
-
Cost of revenue
8.00K
4.00K
4.00K
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
273.16M
232.30M
232.30M
492.02M
Operating expense
273.16M
232.30M
232.30M
492.02M
Total operating expenses
273.17M
232.30M
232.30M
492.02M
Operating income
-273.14M
-232.29M
-232.29M
-492.02M
Other non operating income
3.98M
2.39M
2.39M
4.27M
EBT including unusual items
-275.87M
-230.76M
-230.76M
-491.75M
EBT excluding unusual items
-274.50M
-230.47M
-230.47M
-491.75M
Income tax expense
475.00K
605.00K
605.00K
605.00K
Effective tax rate
-0.17%
-0.26%
-0.26%
-0.12%
Other operating expenses
-
-
-
-
Net income
-276.35M
-231.37M
-231.37M
-492.36M
Net profit margin
-837,421.21%
-1,402,233.33%
-1,402,233.33%
-
Earnings per share
-
-
-
-
Interest and investment income
14.00K
6.00K
6.00K
-
Interest expense
-
-
-
-
Net interest expenses
14.00K
6.00K
6.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more